Список литературы

Strohmaier W. Epidemiologie und Pathogenese der Urolithiasis. Die Urologie. Part of the series Springer Reference Medizin. 2016: 473 - 478.

КонсультантПлюс: примечание.

Нумерация пунктов дана в соответствии с официальным текстом документа.

2. Бакетин П.С., Моллаев Р.А., Д.А. Мазуренко, Григорьев В.Е. и соавт. Патогенетические варианты мочекаменной болезни. Педиатр. 2017; N 8 (1): 89 - 99.

3. Coe F.L., Evan A.P., Worcester E.M., Lingeman J.E. Three pathways for human kidney stone formation. Urol Res. 2010; N 38 (3): 147 - 60. doi: 10.1007/s00240-010-0271-8.

4. Evan A.P., Lingeman J., Coe F., Shao Y., Miller N., et al. Renal histopathology of stone-forming patients with distal renal tubular acidosis. Kidney Int. 2007; N 71 (8): 795 - 801.

5. Kok D.J., Khan S.R. Calcium oxalate nephrolithiasis, a free or fixed particle disease. Kidney Int. 1994; N 46 (3): 847 - 54.

6. Белай С.И., Довбыш М.А., Белай И.М. Мочекаменная болезнь: актуальность вопроса и перспективы его развития. Вестник ВГМУ. Украина. 2016; N 15 (5): 19 - 26.

7. Борисов В.В. Мочекаменная болезнь. Терапия больных камнями почек и мочеточников. М., 2011. с. 96.

8. Trinchieri A., Curhan G., Karlsen S., Jun Wu К. Epidemiology. Stone Disease. Paris: Health Publications, 2003; с. 13 - 30.

9. Stamatelou K.K., Francis M.E., Jones C.A., Nyberg L.M., Curhan G.C. Time trends in reported prevalence of kidney stones in the United States: 1976 - 1994. Kidney Int. 2003; N 63 (5): 1817 - 23.

10. Trinchieri A., Ostini F., Nespoli R., Rovera F., Montanari E., et al. A prospective study of recurrence rate and risk factors for recurrence after a first renal stone. J Urol. 1999; N 162 (1): 27 - 30. doi: 10.1097/00005392-199907000-00007.

11. Rule A.D., Lieske J.C., Li X., Melton L.J.3rd., Krambeck A.E., et al. The ROKS nomogram for predicting a second symptomatic stone episode. J Am Soc Nephrol. 2014; N 25 (12): 2878 - 86. doi: 10.1681/ASN.2013091011.

12. Гаджиев Н.К., Бровкин С.С., Григорьев В.Е., Дмитриев В.В., Малхасян В.А., и др. Метафилактика мочекаменной болезни: новый взгляд, современный подход, мобильная реализация. Урология. 2017; 1: 124 - 129.

13. Hesse A., 00000005.wmz., Wilbert D., 00000006.wmz, Alken P. Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol. 2003; N 44 (6): 709 - 13.

14. Leusmann D.B. Whewellite, weddellite and company: where do all the strange names originate? BJU Int. 2000; N 86 (4): 411 - 3.

15. Leusmann D.B., Blaschke R., Schmandt W. Results of 5,035 stone analyses: a contribution to epidemiology of urinary stone disease. Scand J Urol Nephrol. 1990; N 24 (3): 205 - 10.

16. Kim S.C., Burns E.K., Lingeman J.E., Paterson R.F., McAteer J.A., et al. Cystine calculi: correlation of CT-visible structure, CT number, and stone morphology with fragmentation by shock wave lithotripsy. Urol Res. 2007; N 35 (6): 319 - 24.

17. Perlmutter A.E., Talug C., Tarry W.F., Zaslau S., Mohseni H., et al. Impact of stone location on success rates of endoscopic lithotripsy for nephrolithiasis. Urology. 2008; N 71 (2): 214 - 7. doi: 10.1016/j.urology.2007.09.023.

18. Eisner B.H., Reese A., Sheth S., Stoller M.L. Ureteral stone location at emergency room presentation with colic. J Urol. 2009; N 182 (1): 165 - 8. doi: 10.1016/j.juro.2009.02.131.

19. Segura J.W., Preminger G.M., Assimos D.G., Dretler S.P., Kahn R.I., et al. Ureteral Stones Clinical Guidelines Panel summary report on the management of ureteral calculi. The American Urological Association. J Urol. 1997; N 158 (5): 1915 - 21.

20. Chung B.I., Aron M., Hegarty N.J., Desai M.M. Ureteroscopic versus percutaneous treatment for medium-size (1 - 2-cm) renal calculi. J Endourol. 2008; N 22 (2): 343 - 6. doi: 10.1089/end.2006.9865.

21. Keoghane S., Walmsley B. Hodgson D. The natural history of untreated renal tract calculi. BJU Int. 2010; N 105 (12): 1627 - 9. doi: 10.1111/j.1464-410X.2010.09389.x.

22. Straub M., Strohmaier W.L., Berg W., Beck B., Hoppe B., et al. Diagnosis and metaphylaxis of stone disease. Consensus concept of the National Working Committee on Stone Disease for the upcoming German Urolithiasis Guideline. World J Urol. 2005; N 23 (5): с. 309 - 23.

23. Hesse A., Tiselius B.H., Siener S.R., et al. Urinary Stones, Diagnosis, Treatment and Prevention of Recurrence. 3rd edition. 2009, Basel.

24. Basiri A., Shakhssalim N. Khoshdel A.R., Javaherforooshzadeh A., Basiri H., et al. Familial relations and recurrence pattern in nephrolithiasis: new words about old subjects. Urol J. 2010 N 7 (2): 81 - 6.

25. Goldfarb D.S., Fischer M.E., Keich Y., Goldberg J. A twin study of genetic and dietary influences on nephrolithiasis: a report from the Vietnam Era Twin (VET) Registry. Kidney Int. 2005; N 67 (3): 1053 - 61.

26. Asplin J.R., Coe F.L. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. J Urol. 2007; N 177 (2): 565 - 9.

27. Gonzalez R.D., Canales B.K. Kidney stone risk following modern bariatric surgery. Curr Urol Rep. 2014; N 15 (5): 401. doi: 10.1007/s11934-014-0401-x.

28. Rendina D., De Filippo G., D"Elia L., Strazzullo P. Metabolic syndrome and nephrolithiasis: a systematic review and meta-analysis of the scientific evidence. J Nephrol. 2014; N 27 (4): 371 - 6. doi: 10.1007/s40620-014-0085-9.

29. Dell"Orto V.G., Belotti E.A., Goeggel-Simonetti B., Simonetti G.D., Ramelli G.P., et al. Metabolic disturbances and renal stone promotion on treatment with topiramate: a systematic review. Br J Clin Pharmacol. 2014; N 77 (6): 958 - 64. doi: 10.1111/bcp.12283.

30. Mufti U.B., Nalagatla S.K. Nephrolithiasis in autosomal dominant polycystic kidney disease. J Endourol. 2010; N 24 (10): 1557 - 61. doi: 10.1089/end.2010.0093.

31. Chen Y., DeVivo M.J., Roseman J.M. Current trend and risk factors for kidney stones in persons with spinal cord injury: a longitudinal study. Spinal Cord. 2000; N 38 (6): 346 - 53.

32. Hara A., Yang W.Y., Petit T., Zhang Z.Y., Gu Y.M., et al. Incidence of nephrolithiasis in relation to environmental exposure to lead and cadmium in a population study. Environ Res. 2016; 145: 1 - 8. doi: 10.1016/j.envres.2015.11.013.

33. Wimpissinger F., 00000007.wmz, Kheyfets O., Stackl W. The silence of the stones: asymptomatic ureteral calculi. J Urol. 2007; N 178 (4): 1341 - 4.

34. 00000008.wmz, A. Skolarikos, A. Neisius, 00000009.wmz, C. Seitz, K. Thomas EAU Guidelines. Urolithiasis. presented at the EAU Annual Congress Barcelona 2019. ISBN 978-94-92671-04-2. https://uroweb.org/guideline/urolithiasis/

35. Plot C, Evliyaoglu O, Erkan REC, 00000010.wmz, Tugrul 00000011.wmz, Aslaner A et al. Comparison of urine microscopy and urine culture results of patients considered to have urinary tract infection. Am J Exp Clin Res. 2015; 2(3): 118 - 20.

36. Parmar M.S. Kidney stones. BMJ. 2004; N 328 (7453): 1420 - 1424. doi: 10.1136/bmj.328.7453.1420.

37. Miller N.L., Lingeman J.E. Management of kidney stones. BMJ. 2007; N 334 (7591): 468 - 72. doi: 10.1136/bmj.39113.480185.80.

38. Pearle M.S., Asplin J.R., Coe F.L., Rodregs A., Worcester E.M. Medical management of urolithiasis. 2nd International consultation on Stone Disease. Health Publications, 2008; 57 - 85.

39. Matlaga BR, Shah OD, Assimos DG. Drug-induced urinary calculi. Rev Urol. 2003 Fall; 5(4): 227 - 31.

40. Wimpissinger F., 00000012.wmz, Kheyfets O., Stackl W. The silence of the stones: asymptomatic ureteral calculi. J Urol. 2007; N 178 (4): 1341 - 4.

41. G. Bonkat (Co-chair), R. Pickard (Co-chair), R. Bartoletti, et al., EAU Guidelines on Urological Infections, in EAU Guidelines, Edn. published as the 32nd EAU Annual Meeting, London, E.A.o.U.G. Office, Editor. 2017, European Association of Urology Guidelines Office: Arnhem, The Netherlands.

42. Worster A., Preyra I., Weaver B., Haines T. The accuracy of noncontrast helical computed tomography versus intravenous pyelography in the diagnosis of suspected acute urolithiasis: a meta-analysis. Ann Emerg Med. 2002; N 40 (3): 280 - 6.

43. Miller O.F., Rineer S.K., Reichard S.R., Buckley R.G., Donovan M.S., et al. Prospective comparison of unenhanced spiral computed tomography and intravenous urogram in the evaluation of acute flank pain. Urology. 1998; N 52 (6): 982 - 7.

44. Yilmaz S., Sindel T., Arslan G., Ozkaynak C., Karaali K., et al. Renal colic: comparison of spiral CT, US and IVU in the detection of ureteral calculi. Eur Radiol. 1998; N 8 (2): 212 - 7. doi: 10.1007/s003300050364.

45. Smith R.C., Rosenfield A.T., Choe K.A., Essenmacher K.R., Verga M., et al. Acute flank pain: comparison of non-contrast-enhanced CT and intravenous urography. Radiology. 1995; N 194 (3): 789 - 94.

46. Pfister S.A., Deckart A., Laschke S., Dellas S., Otto U., et al. Unenhanced helical computed tomography vs intravenous urography in patients with acute flank pain: accuracy and economic impact in a randomized prospective trial. Eur Radiol. 2003; N 13 (11): 2513 - 20. doi: 10.1007/s00330-003-1937-1.

47. Sheafor D.H., Hertzberg B.S., Freed K.S., Carroll B.A., Keogan M.T., et al. Nonenhanced helical CT and US in the emergency evaluation of patients with renal colic: prospective comparison. Radiology. 2000; N 217 (3): 792 - 7.

48. Smith-Bindman R., Aubin C., Bailitz J., Bengiamin R.N., Camargo C.A. Jr, et al. Ultrasonography versus computed tomography for suspected nephrolithiasis. N Engl J Med. 2014; N 371 (12): 1100 - 10. doi: 10.1056/NEJMoa1404446.

49. Levine J.A., Neitlich J., Verga M., Dalrymple N., Smith R.C. Ureteral calculi in patients with flank pain: correlation of plain radiography with unenhanced helical CT. Radiology. 1997; N 204 (1): 27 - 31.

50. El-Nahas A.R., El-Assmy A.M., Mansour O., Sheir K.Z. A prospective multivariate analysis of factors predicting stone disintegration by extracorporeal shock wave lithotripsy: the value of high-resolution noncontrast computed tomography. Eur Urol. 2007; N 51 (6): 1688 - 93.

51. Patel T., Kozakowski K., Hruby G., Gupta M. Skin to stone distance is an independent predictor of stone-free status following shockwave lithotripsy. J Endourol. 2009; N 23 (9): 1383 - 5. doi: 10.1089/end.2009.0394.

52. Zarse C.A., Hameed T.A., Jackson M.E., Pishchalnikov Y.A., Lingeman J.E., et al. CT visible internal stone structure, but not Hounsfield unit value, of calcium oxalate monohydrate (COM) calculi predicts lithotripsy fragility in vitro. Urol Res. 2007; N 35 (4): с. 201 - 6. doi: 10.1007/s00240-007-0104-6.

53. Schwartz B.F., Schenkman N., Armenakas N.A., Stoller M.L. Imaging characteristics of indinavir calculi. J Urol. 1999; N 161 (4): 1085 - 7.

54. Sourtzis S., Thibeau J.F., Damry N., Raslan A., Vandendris M., et al. Radiologic investigation of renal colic: unenhanced helical CT compared with excretory urography. AJR Am J Roentgenol. 1999; N 172 (6): 1491 - 4.

55. Niall O., Russell J., MacGregor R., Duncan H., Mullins J. A comparison of noncontrast computerized tomography with excretory urography in the assessment of acute flank pain. J Urol. 1999; N 161 (2): 534 - 7.

56. Wang J.H., Shen S.H., Huang S.S., Chang C.Y. Prospective comparison of unenhanced spiral computed tomography and intravenous urography in the evaluation of acute renal colic. J Chin Med Assoc. 2008; N 71 (1): с. 30 - 36. doi: 10.1016/S1726-4901(08)70069-8.

57. Shine S. Urinary calculus: IVU vs. CT renal stone? A critically appraised topic. Abdom Imaging. 2008; N 33 (1): с. 41 - 3.

58. Ulusan S., Koc Z., Tokmak N. Accuracy of sonography for detecting renal stone: comparison with CT. J Clin Ultrasound. 2007; N 35 (5): с. 256 - 61. doi: 10.1002/jcu.20347

59. Caoili E.M., Cohan R.H., Korobkin M., Platt J.F., Francis I.R., Faerber G.J., Montie J.E., Ellis J.H. Urinary tract abnormalities: initial experience with multi-detector row CT urography. Radiology. 2002; N 222 (2): 353 - 60.

60. Thomson J.M., Glocer J., Abbott C., Maling T.M., Mark S. Computed tomography versus intravenous urography in diagnosis of acute flank pain from urolithiasis: a randomized study comparing imaging costs and radiation dose. Australas Radiol. 2001; N 45 (3): 291 - 7.

61. Poletti P.A. Platon A., Rutschmann O.T., Schmidlin F.R., Iselin C.E., et al. Low-dose versus standard-dose CT protocol in patients with clinically suspected renal colic. AJR Am J Roentgenol. 2007; N 188 (4): 927 - 33. doi: 10.2214/AJR.06.0793.

62. Kluner C., Hein P.A., Gralla O., Hein E., Hamm B., et al. Does ultra-low-dose CT with a radiation dose equivalent to that of KUB suffice to detect renal and ureteral calculi? J Comput Assist Tomogr. 2006; N 30 (1): 44 - 50.

63. Jellison F.C., Smith J.C., Heldt J.P., Spengler N.M., Nicolay L.I., et al. Effect of low dose radiation computerized tomography protocols on distal ureteral calculus detection. J Urol. 2009; N 182 (6): 2762 - 7. doi: 10.1016/j.juro.2009.08.042.

64. Niemann T., Kollmann T., Bongartz G. Diagnostic performance of low-dose CT for the detection of urolithiasis: a meta-analysis. AJR Am J Roentgenol. 2008; N 191 (2): 396 - 401. doi: 10.2214/AJR.07.3414.

65. Xiang H., Chan M., Brown V., Huo Y.R., Chan L., et al. Systematic review and meta-analysis of the diagnostic accuracy of low-dose computed tomography of the kidneys, ureters and bladder for urolithiasis. J Med Imaging Radiat Oncol. 2017; N 61 (5): 582 - 590. doi: 10.1111/1754-9485.12587.

66. Mancini J.G., Ferrandino M.N. The impact of new methods of imaging on radiation dosage delivered to patients. Curr Opin Urol. 2010; N 20 (2): 163 - 8. doi: 10.1097/MOU.0b013e3283353bd9.

67. McCollough C.H., Primak A.N., Braun N., Kofler J., Yu L., Christner J. Strategies for reducing radiation dose in CT. Radiol Clin North Am. 2009; N 47 (1): 27 - 40. doi: 10.1016/j.rcl.2008.10.006.

68. Mulkens T.H., Daineffe S., De Wijngaert R., Bellinck P., Leonard A., et al. Urinary stone disease: comparison of standard-dose and low-dose with 4D MDCT tube current modulation. AJR Am J Roentgenol. 2007; N 188 (2): 553 - 62. doi: 10.2214/AJR.05.1863

69. Kim B.S., Hwang I.K., Choi Y.W., Namkung S., Kim H.C., et al. Low-dose and standard-dose unenhanced helical computed tomography for the assessment of acute renal colic: prospective comparative study. Acta Radiol. 2005; N 46 (7): 756 - 63.

70. Kawashima A., Sandler C.M., Ernst R.D., Tamm E.P., Goldman S.M., et al. CT evaluation of renovascular disease. Radiographics. 2000; N 20 (5): 1321 - 40. doi: 10.1148/radiographics.20.5.g00se141321

71. Agochukwu N., Huber S., Spektor M., Goehler A., Israel G.M. Differentiating Renal Neoplasms From Simple Cysts on Contrast-Enhanced CT on the Basis of Attenuation and Homogeneity. AJR Am J Roentgenol. 2017; N 208 (4): 801 - 804. doi: 10.2214/AJR.16.17119.

72. Schiappacasse G., Aguirre J., Soffia P., Silva C.S., Zilleruelo N. CT findings of the main pathological conditions associated with horseshoe kidneys. Br J Radiol. 2015; N 88 (1045): 20140456. doi: 10.1259/bjr.20140456.

73. Rao P.N. Imaging for kidney stones. World J Urol. 2004; N 22 (5): 323 - 7. doi: 10.1007/s00345-004-0413-0.

74. Ray A.A., Ghiculete D., Pace K.T., Honey R.J. Limitations to ultrasound in the detection and measurement of urinary tract calculi. Urology. 2010; N 76 (2): 295 - 300. doi: 10.1016/j.urology.2009.12.015.

75. Chua M.E., Gomez O.R., Sapno L.D., Lim S.L., Morales M.L.Jr. Use of computed tomography scout film and Hounsfield unit of computed tomography scan in predicting the radio-opacity of urinary calculi in plain kidney, ureter and bladder radiographs. Urol Ann. 2014; N 6 (3): 218 - 23. doi: 10.4103/0974-7796.134270.

76. Jackman S.V., Potter S.R., Regan F., Jarrett T.W. Plain abdominal x-ray versus computerized tomography screening: sensitivity for stone localization after nonenhanced spiral computerized tomography. J Urol. 2000; N 164 (2): 308 - 10.

77. Heidenreich A., Desgrandschamps F., Terrier F. Modern approach of diagnosis and management of acute flank pain: review of all imaging modalities. Eur Urol. 2002; N 41 (4): 351 - 62.

78. Mutgi A., Williams J.W., Nettleman M. Renal colic. Utility of the plain abdominal roentgenogram. Arch Intern Med. 1991; N 151 (8): 1589 - 92.

79. Kennish S.J., Bhatnagar P., Wah T.M., Bush S., Irving H.C. Is the KUB radiograph redundant for investigating acute ureteric colic in the non-contrast enhanced computed tomography era? Clin Radiol. 2008; N 63 (10): 1131 - 5. doi: 10.1016/j.crad.2008.04.012.

80. Campschroer T., Zhu X., Vernooij R.W., Lock MT.WT. Alpha-blockers as medical expulsive therapy for ureteral stones // Cochrane Database of Systematic Reviews. 2018; (4): CD008509. doi: 10.1002/14651858.CD008509.pub3.

81. Furyk, J.S., Chu, K., Banks, C., Greenslade, J., Keijzers, G., Thom, O., ... Narula, R. (2016). Distal Ureteric Stones and Tamsulosin: A Double-Blind, Placebo-Controlled, Randomized, Multicenter Trial. Annals of Emergency Medicine, 67(1), 86-95.e2. doi: 10.1016/j.annemergmed.2015.06.001.

82. Lucarelli G., Ditonno P., Bettocchi C., Grandaliano G., Gesualdo L., et al. Delayed relief of ureteral obstruction is implicated in the long-term development of renal damage and arterial hypertension in patients with unilateral ureteral injury. J Urol. 2013; N 189 (3): 960 - 5. doi: 10.1016/j.juro.2012.08.242.

83. Hsu Y.P., Hsu C.W., Bai C.H., Cheng S.W., Chen K.C., et al. Silodosin versus tamsulosin for medical expulsive treatment of ureteral stones: A systematic review and meta-analysis. PLoS One. 2018; N 13 (8): e0203035. doi: 10.1371/journal.pone.0203035.

84. Liatsikos E.N., Katsakiori P.F., Assimakopoulos K., Voudoukis T., Kallidonis P., et al. Doxazosin for the management of distal-ureteral stones. J Endourol. 2007; N 21 (5): 538 - 41. doi: 10.1089/end.2006.0107.

85. Hollingsworth J.M., Rogers M.A., Kaufman S.R., Bradford T.J., Saint S., et al. Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet. 2006; N 368 (9542): 1171 - 9. doi: 10.1016/S0140-6736(06)69474-9.

86. Lojanapiwat B., Kochakarn W., Suparatchatpan N., Lertwuttichaikul K. Effectiveness of low-dose and standard-dose tamsulosin in the treatment of distal ureteric stones: a randomized controlled study. J Int Med Res. 2008; N 36 (3): 529 - 36. doi: 10.1177/147323000803600318.

87. Wang C.J., Huang S.W., Chang C.H. Efficacy of an alpha1 blocker in expulsive therapy of lower ureteral stones. J Endourol. 2008; N 22 (1): с. 41 - 46. doi: 10.1089/end.2007.0133.

88. Kaneko T., Matsushima H., Morimoto H., Tsuzaka Y., Homma Y. Efficacy of low dose tamsulosin in medical expulsive therapy for ureteral stones in Japanese male patients: a randomized controlled study. Int J Urol. 2010; N 17 (5): 462 - 5. doi: 10.1111/j.1442-2042.2010.02499.x.

89. Yilmaz E., Batislam E., Basar M.M., Tuglu D., Ferhat M., et al. The comparison and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones. J Urol. 2005; N 173 (6): с. 2010 - 2. doi: 10.1097/01.ju.0000158453.60029.0a.

90. Zehri A.A., Ather M.H., Abbas F., Biyabani S.R. Preliminary study of efficacy of doxazosin as a medical expulsive therapy of distal ureteric stones in a randomized clinical trial. Urology. 2010; N 75 (6): с. 1285 - 8. doi: 10.1016/j.urology.2009.10.069.

91. Mohseni M.G., Hosseini S.R., Alizadeh F. Efficacy of terazosin as a facilitator agent for expulsion of the lower ureteral stones. Saudi Med J. 2006; N 27 (6): 838 - 40.

92. Agrawal M., Gupta M., Gupta A., Agrawal A., Sarkari A., et al. Prospective randomized trial comparing efficacy of alfuzosin and tamsulosin in management of lower ureteral stones. Urology. 2009; N 73 (4): 706 - 709. doi: 10.1016/j.urology.2008.11.013.

93. Pedro R.N., Hinck B., Hendlin K., Feia K., Canales B.K., et al. Alfuzosin stone expulsion therapy for distal ureteral calculi: a double-blind, placebo controlled study. J Urol. 2008; N 179 (6): 2244 - 7. doi: 10.1016/j.juro.2008.01.141.

94. Ahmed A.F., Al-Sayed A.Y. Tamsulosin versus Alfuzosin in the Treatment of Patients with Distal Ureteral Stones: Prospective, Randomized, Comparative Study. Korean J Urol. 2010; N 51 (3): 193 - 7. doi: 10.4111/kju.2010.51.3.193.

95. Chau L.H., Tai D.C., Fung B.T., Li J.C., Fan C.W., et al. Medical expulsive therapy using alfuzosin for patient presenting with ureteral stone less than 10 mm: a prospective randomized controlled trial. Int J Urol. 2011; N 18 (7): 510 - 4. doi: 10.1111/j.1442-2042.2011.02780.x.

96. Tsuzaka Y., Matsushima H., Kaneko T., Yamaguchi T., Homma Y. Naftopidil vs silodosin in medical expulsive therapy for ureteral stones: a randomized controlled study in Japanese male patients. Int J Urol. 2011; N 18 (11): с. 792 - 5. doi: 10.1111/j.1442-2042.2011.02850.x.

97. Itoh Y., Okada A. Yasui T. Hamamoto S. Hirose M. et al. Efficacy of selective 00000013.wmz adrenoceptor antagonist silodosin in the medical expulsive therapy for ureteral stones. Int J Urol. 2011; N 18 (9): 672 - 4. doi: 10.1111/j.1442-2042.2011.02810.x.

98. Sairam K. Should we SUSPEND MET? Not really. Cent European J Urol. 2016; N 69 (2): 183. doi: 10.5173/ceju.2016.864.

99. Rodman J.S., Williams J.J., Peterson C.M. Dissolution of uric acid calculi. J Urol. 1984; N 131 (6): 1039 - 44.

100. Becker G. The CARI guidelines. Kidney stones: uric acid stones. Nephrology (Carlton). 2007; 12 (1): 21 - 5. doi: 10.1111/j.1440-1797.2007.00774.x.

101. Bultitude M., Rees J. Management of renal colic. BMJ. 2012; 345: e5499. doi: 10.1136/bmj.e5499.

102. El-Gamal O., El-Bendary M., Ragab M., Rasheed M. Role of combined use of potassium citrate and tamsulosin in the management of uric acid distal ureteral calculi. Urol Res. 2012; N 40 (3): 219 - 24. doi: 10.1007/s00240-011-0406-6.

103. Preminger G.M., Tiselius H.G., Assimos D.G., Alken P., Buck A.C., et al. 2007 Guideline for the management of ureteral calculi. Eur Urol. 2007; N 52 (6): 1610 - 31.

104. Skolarikos A., Laguna M.P., Alivizatos G., Kural A.R., de la Rosette J.J. The role for active monitoring in urinary stones: a systematic review. J Endourol. 2010; N 24 (6): 923 - 30. doi: 10.1089/end.2009.0670.

105. Skolarikos A., Mitsogiannis H., Deliveliotis C. Indications, prediction of success and methods to improve outcome of shock wave lithotripsy of renal and upper ureteral calculi. Arch Ital Urol Androl. 2010; N 82 (1): 56 - 63.

106. Pearle M.S., Pierce H.L., Miller G.L., Summa J.A., Mutz J.M., et al. Optimal method of urgent decompression of the collecting system for obstruction and infection due to ureteral calculi. J Urol. 1998; N 160 (4): 1260 - 4.

107. Mokhmalji H., Braun P.M., Martinez Portillo F.J., Siegsmund M., Alken P., et al. Percutaneous nephrostomy versus ureteral stents for diversion of hydronephrosis caused by stones: a prospective, randomized clinical trial. J Urol. 2001; N 165 (4): 1088 - 92.

108. Yoshimura K., Utsunomiya N., Ichioka K., Ueda N., Matsui Y., et al. Emergency drainage for urosepsis associated with upper urinary tract calculi. J Urol. 2005; N 173 (2): 458 - 62. doi: 10.1097/01.ju.0000150512.40102.bb.

109. Ramsey S., Robertson A., Ablett M.J., Meddings R.N., Hollins G.W., et al. Evidence-based drainage of infected hydronephrosis secondary to ureteric calculi. J Endourol. 2010; N 24 (2): 185 - 9. doi: 10.1089/end.2009.0361.

110. Иванов В.Ю., Малхасян В.А., Семенякин И.В., Гаджиев Н.К., Тедеев А.В., и др. Выбор оптимального метода дренирования верхних мочевых путей при остром обструктивном пиелонефрите. Экспериментальная и клиническая урология. 2017; N 1: 58 - 67.

111. Marien T., Mass A.Y., Shah O. Antimicrobial resistance patterns in cases of obstructive pyelonephritis secondary to stones. Urology. 2015; N 85 (1): 64 - 8. doi: 10.1016/j.urology.2014.10.007.

112. Mariappan P., Loong C.W. Midstream urine culture and sensitivity test is a poor predictor of infected urine proximal to the obstructing ureteral stone or infected stones: a prospective clinical study. J Urol. 2004; N 171 (6): 2142 - 5.

113. Naboka Y.L., Gudima I.A., Mitusova E.V., Bedzhanyan S.K., Morgun P.P. Antimicrobial resistance of uropathogens in patients with acute obstructive pyelonephritis. Urologiia. 2017; 4: 27 - 31.

114. Pasiechnikov S., Buchok O., Sheremeta R., Banyra O. Empirical treatment in patients with acute obstructive pyelonephritis. Infect Disord Drug Targets. 2015; N 15 (3): 163 - 70.

115. Vahlensieck W., Friess D., Fabry W., Waidelich R., Bschleipfer T. Long-term results after acute therapy of obstructive pyelonephritis. Urol Int. 2015; N 94 (4): 436 - 41. doi: 10.1159/000368051.

116. Wagenlehner F.M., Tandogdu Z., Bjerklund Johansen T.E. An update on classification and management of urosepsis. Curr Opin Urol. 2017; N 27 (2): 133 - 137. doi: 10.1097/MOU.0000000000000364.

117. Wagenlehner F.M., Lichtenstern C., Rolfes C., Mayer K., Uhle F., et al. Diagnosis and management for urosepsis. Int J Urol. 2013; N 20 (10): 963 - 70. doi: 10.1111/iju.12200.

118. Wagenlehner F.M., Pilatz A., Weidner W. Urosepsis - from the view of the urologist. Int J Antimicrob Agents. 2011; N 38: 51 - 57. doi: 10.1016/j.ijantimicag.2011.09.007.

119. Dellinger R.P., Levy M.M., Carlet J.M. et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008; N 36 (1): 296 - 327.

120. Малхасян В.А., Иванов В.Ю., Ходырева Л.А., Дударева А.А., Куприянов Ю.А., и др. Анализ оказания специализированной медицинской помощи пациентам с острым обструктивным пиелонефритом в урологических стационарах г. Москвы. Экспериментальная и клиническая урология. 2016; N 4: 26 - 30.

121. Cui X., Ji F., Yan H., Ou T.W., Jia C.S., et al. Comparison between extracorporeal shock wave lithotripsy and ureteroscopic lithotripsy for treating large proximal ureteral stones: a meta-analysis. Urology. 2015; N 85 (4): 748 - 56. doi: 10.1016/j.urology.2014.11.041.

122. Drake T., Grivas N., Dabestani S., Knoll T., Lam T., et al. What are the Benefits and Harms of Ureteroscopy Compared with Shock-wave Lithotripsy in the Treatment of Upper Ureteral Stones? A Systematic Review. Eur Urol. 2017; N 72 (5): 772 - 786. doi: 10.1016/j.eururo.2017.04.016.

123. Aboumarzouk O.M., Kata S.G., Keeley F.X., McClinton S., Nabi G. Extracorporeal shock wave lithotripsy (ESWL) versus ureteroscopic management for ureteric calculi. Cochrane Database Syst Rev. 2012; N 16 (5): CD006029.

124. Xu Y., Lu Y., Li J., Luo S., Liu Y., et al. A meta-analysis of the efficacy of ureteroscopic lithotripsy and extracorporeal shock wave lithotripsy on ureteral calculi. Acta Cir Bras. 2014; N 29 (5): 346 - 52.

125. Ishii H., Couzins M., Aboumarzouk O., Biyani C.S., Somani B.K. Outcomes of Systematic Review of Ureteroscopy for Stone Disease in the Obese and Morbidly Obese Population. J Endourol. 2016; N 30 (2): 135 - 45. doi: 10.1089/end.2015.0547.

126. Delakas D., Karyotis I., Daskalopoulos G., Lianos E., Mavromanolakis E. Independent predictors of failure of shockwave lithotripsy for ureteral stones employing a second-generation lithotripter. J Endourol. 2003; N 17 (4): 201 - 5.

127. Yang C., Li S., Cui Y. Comparison of YAG Laser Lithotripsy and Extracorporeal Shock Wave Lithotripsy in Treatment of Ureteral Calculi: A Meta-Analysis. Urol Int. 2017; N 98 (4): 373 - 381. doi: 10.1159/000452610.

128. Ouzaid I., Al-qahtani S., Dominique S., Hupertan V., Fernandez P., et al. A 970 Hounsfield units (HU) threshold of kidney stone density on non-contrast computed tomography (NCCT) improves patients" selection for extracorporeal shockwave lithotripsy (ESWL): evidence from a prospective study. BJU Int. 2012; N 110 (11): 438 - 42. doi: 10.1111/j.1464-410X.2012.10964.x.

129. Shinde S., Al Balushi Y., Hossny M., Jose S., Al Busaidy S. Factors Affecting the Outcome of Extracorporeal Shockwave Lithotripsy in Urinary Stone Treatment. Oman Med J. 2018; N 33 (3): 209 - 217. doi: 10.5001/omj.2018.39.

130. Razvi H., Fuller A., Nott L., 00000014.wmz, Leistner R., et al. Risk factors for perinephric hematoma formation after shockwave lithotripsy: a matched case-control analysis. J Endourol. 2012; N 26 (11): 1478 - 82. doi: 10.1089/end.2012.0261.

131. Schnabel M.J., Gierth M., 00000015.wmz, Chaussy C.G., Burger M., et al. Antiplatelet and anticoagulative medication during shockwave lithotripsy. J Endourol. 2014; N 28 (9): 1034 - 9. doi: 10.1089/end.2014.0162.

132. Elkoushy M.A., Violette P.D., Andonian S. Ureteroscopy in patients with coagulopathies is associated with lower stone-free rate and increased risk of clinically significant hematuria. Int Braz J Urol. 2012; N 38 (2): 195 - 202.

133. Watterson J.D., Girvan A.R., Cook A.J., Beiko D.T., Nott L., et al. Safety and efficacy of holmium: YAG laser lithotripsy in patients with bleeding diatheses. J Urol. 2002; N 168 (2): 442 - 5.

134. Aboumarzouk O.M., Somani B.K., Monga M. Flexible ureteroscopy and holmium: YAG laser lithotripsy for stone disease in patients with bleeding diathesis: a systematic review of the literature. Int Braz J Urol. 2012; N 38(3): 298 - 305.

135. Toepfer N.J., Baylor K., Henry Y., Simmons J., Berger P.B. The effect of antiplatelet and anticoagulant therapy on the clinical outcome of patients undergoing ureteroscopy. Urology. 2013; N 82 (4): 773 - 9. doi: 10.1016/j.urology.2013.05.019.

136. Turna B, Stein R.J., Smaldone M.C., Santos B.R., Kefer J.C., et al. Safety and efficacy of flexible ureterorenoscopy and holmium: YAG lithotripsy for intrarenal stones in anticoagulated cases. J Urol. 2008; N 179 (4): 1415 - 9. doi: 10.1016/j.juro.2007.11.076.

137. Sharaf A., Amer T., Somani B.K., Aboumarzouk O.M. Ureteroscopy in Patients with Bleeding Diatheses, Anticoagulated, and on Anti-Platelet Agents: A Systematic Review and Meta-Analysis of the Literature. J Endourol. 2017; N 31 (12): 1217 - 1225. doi: 10.1089/end.2017.0253.

138. Wang Q., Guo J., Hu H., Lu Y., Zhang J., et al. Rigid ureteroscopic lithotripsy versus percutaneous nephrolithotomy for large proximal ureteral stones: A meta-analysis. PLoS One. 2017; N 12 (2): e0171478. doi: 10.1371/journal.pone.0171478.

139. Wang Y., Zhong B., Yang X., Wang G., Hou P., et al. Comparison of the efficacy and safety of URSL, RPLU, and MPCNL for treatment of large upper impacted ureteral stones: a randomized controlled trial. BMC Urol. 2017; N 17 (1): 50. doi: 10.1186/s12894-017-0236-0.

140. Wu T., Duan X., Chen S., Yang X., Tang T., Cui S. Ureteroscopic Lithotripsy versus Laparoscopic Ureterolithotomy or Percutaneous Nephrolithotomy in the Management of Large Proximal Ureteral Stones: A Systematic Review and Meta-Analysis. Urol Int. 2017; N 99 (3): 308 - 319. doi: 10.1159/000471773.

141. Topaloglu H., Karakoyunlu N., Sari S., Ozok H.U., Sagnak L., et al. A comparison of antegrade percutaneous and laparoscopic approaches in the treatment of proximal ureteral stones. Biomed Res Int. 2014; 2014:691946. doi: 10.1155/2014/691946.

142. Prakash J., Singh V., Kumar M., Kumar M., Sinha R.J., et al. Retroperitoneoscopic versus open mini-incision ureterolithotomy for upper- and mid-ureteric stones: a prospective randomized study. Urolithiasis. 2014; N 42 (2): 133 - 9. doi: 10.1007/s00240-013-0624-1.

143. Skolarikos A., Papatsoris A.G., Albanis S., Assimos D. Laparoscopic urinary stone surgery: an updated evidence-based review. Urol Res. 2010; N 38 (5): 337 - 44. doi: 10.1007/s00240-010-0275-4.

144. Kumar A., Vasudeva P., Nanda B., Kumar N., Jha S.K., Singh H. A Prospective Randomized Comparison Between Laparoscopic Ureterolithotomy and Semirigid Ureteroscopy for Upper Ureteral Stones > 2 cm: A Single-Center Experience. J Endourol. 2015; N 29 (11): 1248 - 52. doi: 10.1089/end.2013.0791.

145. Torricelli F.C., Monga M., Marchini G.S., Srougi M., Nahas W.C., Mazzucchi E. Semi-rigid ureteroscopic lithotripsy versus laparoscopic ureterolithotomy for large upper ureteral stones: a meta-analysis of randomized controlled trials. Int Braz J Urol. 2016; N 42 (4): 645 - 54. doi: 10.1590/S1677-5538.IBJU.2015.0696.

146. Kallidonis P., Ntasiotis P., Knoll T., Sarica K., Papatsoris A., et al. Minimally Invasive Surgical Ureterolithotomy Versus Ureteroscopic Lithotripsy for Large Ureteric Stones: A Systematic Review and Meta-analysis of the Literature. Eur Urol Focus. 2017; N 3 (6): 554 - 566. doi: 10.1016/j.euf.2017.04.006.

147. Sun X., Xia S., Lu J., Liu H., Han B., et al. Treatment of large impacted proximal ureteral stones: randomized comparison of percutaneous antegrade ureterolithotripsy versus retrograde ureterolithotripsy. J Endourol. 2008; N 22 (5): 913 - 7. doi: 10.1089/end.2007.0230.

148. Moufid K., Abbaka N., Touiti D., Adermouch L., Amine M., Lezrek M. Large impacted upper ureteral calculi: A comparative study between retrograde ureterolithotripsy and percutaneous antegrade ureterolithotripsy in the modified lateral position. Urol Ann. 2013; N 5 (3): 140 - 6. doi: 10.4103/0974-7796.115729

149. El-Nahas A.R., Eraky I., el-Assmy A.M., Shoma A.M., el-Kenawy M.R., Abdel-Latif M., Mosbah A., Abol-Enein H., Shaaban A.A., Mohsen T., el-Kappany H.A. Percutaneous treatment of large upper tract stones after urinary diversion. Urology. 2006; N 68 (3): 500 - 4.

150. El-Assmy A., El-Nahas A.R., Mohsen T., Eraky I., El-Kenawy M.R., Shaban A.A., Sheir K.Z. Extracorporeal shock wave lithotripsy of upper urinary tract calculi in patients with cystectomy and urinary diversion. Urology. 2005; N 66 (3): 510 - 3.

151. Honeck P., Wendt-Nordahl G. Krombach P. Bach T. 00000016.wmz et al. Does open stone surgery still play a role in the treatment of urolithiasis? Data of a primary urolithiasis center. J Endourol. 2009; N 23 (7): 1209 - 12. doi: 10.1089/end.2009.0027.

152. Ohmori K., Matsuda T., Horii Y., Yoshida O. Effects of shock waves on the mouse fetus. J Urol. 1994; N 151 (1): 255 - 8.

153. Smith D.P., Graham J.B., Prystowsky J.B., Dalkin B.L., Nemcek A.A. Jr. The effects of ultrasound-guided shock waves during early pregnancy in Sprague-Dawley rats. J Urol. 1992; N 147 (1): 231 - 4.

154. Chaussy C.G., Fuchs G.J. Current state and future developments of noninvasive treatment of human urinary stones with extracorporeal shock wave lithotripsy. J Urol. 1989; 141: 782 - 789.

155. Mira Moreno A., Montoya Lirola M.D., 00000017.wmz Tabar P.J., Galiano Baena J.F., Tenza Tenza J.A., et al. Incidence of infectious complications after extracorporeal shock wave lithotripsy in patients without associated risk factors. J Urol. 2014; N 192 (5): 1446 - 9. doi: 10.1016/j.juro.2014.05.091.

156. Honey R.J., Ordon M., Ghiculete D., Wiesenthal J.D., Kodama R., et al. A prospective study examining the incidence of bacteriuria and urinary tract infection after shock wave lithotripsy with targeted antibiotic prophylaxis. J Urol. 2013; N 189 (6): 2112 - 7. doi: 10.1016/j.juro.2012.12.063.

157. Lee SW, Yoon S, Do J, et al. The risk factors of recurrent febrile urinary tract infection within 1 year in urinary stone patients with acute obstructive pyelonephritis. Urogenital Tract Infect. 2017; 12: 82 - 8.

158. Westh H., Knudsen F., Hedengran A.M., Weischer M., Mogensen P., et al. Extracorporeal shock wave lithotripsy of kidney stones does not induce transient bacteremia. A prospective study. The Copenhagen Extracorporeal Shock Wave Lithotripsy Study Group. J Urol. 1990; N 144 (1): 15 - 6.

159. Duvdevani M., Lorber G., Gofrit O.N., Latke A., Katz R., et al. Fever after shockwave lithotripsy - risk factors and indications for prophylactic antimicrobial treatment. J Endourol. 2010; N 24 (2): 277 - 81. doi: 10.1089/end.2009.0283.

160. Streem S.B., Yost A. Extracorporeal shock wave lithotripsy in patients with bleeding diatheses. J Urol. 1990; N 144 (6): 1347 - 8.

161. Klingler H.C., Kramer G., Lodde M., Dorfinger K., Hofbauer J., et al. Stone treatment and coagulopathy. Eur Urol. 2003; N 43 (1): 75 - 9.

162. Ruiz H., Saltzman B. Aspirin-induced bilateral renal hemorrhage after extracorporeal shock wave lithotripsy therapy: implications and conclusions. J Urol. 1990; N 143 (4): 791 - 2.

163. Knorr P.A., Woodside J.R. Large perirenal hematoma after extracorporeal shock-wave lithotripsy. Urology. 1990; N 35 (2): 151 - 3.

164. Sare G.M., Lloyd F.R., Stower M.J. Life-threatening haemorrhage after extracorporeal shockwave lithotripsy in a patient taking clopidogrel. BJU Int. 2002; N 90 (4): 469.

165. Alsaikhan B., Andonian S. Shock wave lithotripsy in patients requiring anticoagulation or antiplatelet agents. Can Urol Assoc J. 2011; 5: 53 - 57. doi: 10.5489/cuaj.09140.

166. Rechenmacher S.J., Fang J.C. Bridging Anticoagulation: Primum Non Nocere. J Am Coll Cardiol. 2015; N 66 (12): 1392 - 403. doi: 10.1016/j.jacc.2015.08.002.

167. Altay B., Erkurt B., Albayrak S. A review study to evaluate holmium: YAG laser lithotripsy with flexible ureteroscopy in patients on ongoing oral anticoagulant therapy. Lasers Med Sci. 2017 N 32 (7): 1615 - 1619. doi: 10.1007/s10103-017-2289-4.

168. Carey S.W., Streem S.B. Extracorporeal shock wave lithotripsy for patients with calcified ipsilateral renal arterial or abdominal aortic aneurysms. J Urol. 1992; N 148 (1): 18 - 20.

169. Vasavada S.P., Streem S.B., Kottke-Marchant K., Novick A.C. Pathological effects of extracorporeally generated shock waves on calcified aortic aneurysm tissue. J Urol. 1994; N 152 (1): 45 - 8.

170. Tse G.H., Qazi H.A., Halsall A.K., Nalagatla S.R. Shockwave lithotripsy: arterial aneurysms and vascular complications. J Endourol. 2011; N 25 (3): 403 - 11. doi: 10.1089/end.2010.0355.

171. Wang H., Man L., Li G., Huang G., Liu N., et al. Meta-Analysis of Stenting versus Non-Stenting for the Treatment of Ureteral Stones. PLoS One. 2017; N 12 (1): e0167670. doi: 10.1371/journal.pone.0167670.

172. Shen P., Jiang M., Yang J., Li X., Li Y., et al. Use of ureteral stent in extracorporeal shock wave lithotripsy for upper urinary calculi: a systematic review and meta-analysis. J Urol. 2011; N 186 (4): 1328 - 35. doi: 10.1016/j.juro.2011.05.073.

173. Musa A.A. Use of double-J stents prior to extracorporeal shock wave lithotripsy is not beneficial: results of a prospective randomized study. Int Urol Nephrol. 2008; N 40 (1): 19 - 22. doi: 10.1007/s11255-006-9030-8

174. Ghoneim I.A., El-Ghoneimy M.N., El-Naggar A.E., Hammoud K.M., El-Gammal M.Y., et al. Extracorporeal shock wave lithotripsy in impacted upper ureteral stones: a prospective randomized comparison between stented and non-stented techniques. Urology. 2010; N 75 (1): 45 - 50. doi: 10.1016/j.urology.2009.06.071.

175. Lu Y., Tianyong F., Ping H., Qiang W. Antibiotic Prophylaxis for Shock Wave Lithotripsy in Patients with Sterile Urine Before Treatment May be Unnecessary: A Systematic Review and Meta-Analysis. J Urol. 2012; N 14: S0022-5347(12) 04900-2. doi: 10.1016/j.juro.2012.08.215.

176. Bootsma A.M., Laguna Pes M.P., Geerlings S.E., Goossens A. Antibiotic prophylaxis in urologic procedures: a systematic review. Eur Urol. 2008; N 54 (6): 1270 - 86. doi: 10.1016/j.eururo.2008.03.033.

177. Alexander C.E., Gowland S., Cadwallader J., et al. Routine antibiotic prophylaxis is not required for patients undergoing shockwave lithotripsy: outcomes from a national shockwave lithotripsy database in New Zealand. J Endourol. 2016; 30: 1233 - 8.

178. Wollin D.A., Joyce A.D., Gupta M., Wong MY.C., Laguna P., et al. Antibiotic use and the prevention and management of infectious complications in stone disease. World J Urol. 2017; N 35 (9): 1369 - 1379. doi: 10.1007/s00345-017-2005-9.

179. Li K., Lin T., Zhang C., Fan X., Xu K., et al. Optimal frequency of shock wave lithotripsy in urolithiasis treatment: a systematic review and meta-analysis of randomized controlled trials. J Urol. 2013; N 190 (4): 1260 - 7. doi: 10.1016/j.juro.2013.03.075.

180. Semins M.J., Trock B.J., Matlaga B.R. The effect of shock wave rate on the outcome of shock wave lithotripsy: a meta-analysis. J Urol. 2008; N 179 (1): 194 - 7. doi: 10.1016/j.juro.2007.08.173

181. Connors B.A., Evan A.P., Blomgren P.M., Handa R.K., Willis L.R., et al. Extracorporeal shock wave lithotripsy at 60 shock waves/min reduces renal injury in a porcine model. BJU Int. 2009; N 104 (7): 1004 - 8. doi: 10.1111/j.1464-410X.2009.08520.x

182. Connors B.A., Evan A.P., Blomgren P.M., Handa R.K., Willis L.R., et al. Effect of initial shock wave voltage on shock wave lithotripsy-induced lesion size during step-wise voltage ramping. BJU Int. 2009; N 103 (1): 104 - 7. doi: 10.1111/j.1464-410X.2008.07922.x.

183. Handa R.K., McAteer J.A., Connors B.A., Liu Z., Lingeman J.E., et al. Optimising an escalating shockwave amplitude treatment strategy to protect the kidney from injury during shockwave lithotripsy. BJU Int. 2012; N 110 (11): 1041 - 7. doi: 10.1111/j.1464-410X.2012.11207.x.

184. Skuginna V., Nguyen D.P., Seiler R., Kiss B., Thalmann G.N., et al. Does Stepwise Voltage Ramping Protect the Kidney from Injury During Extracorporeal Shockwave Lithotripsy? Results of a Prospective Randomized Trial. Eur Urol. 2016; N 69 (2): с. 267 - 73. doi: 10.1016/j.eururo.2015.06.017.

185. Maloney M.E., Marguet C.G., Zhou Y., Kang D.E., Sung J.C., et al. Progressive Increase of Lithotripter Output Produces Better in-Vivo Stone Comminution. J Endourol. 2006; N 20 (9): 603 - 606. doi: 10.1089/end.2006.20.603

186. Demirci D., Sofikerim M., 00000018.wmz, 00000019.wmz, 00000020.wmz, et al. Comparison of conventional and step-wise shockwave lithotripsy in management of urinary calculi. J Endourol. 2007; N 21 (12): 1407 - 10.

187. Pishchalnikov Y.A., Neucks J.S., VonDerHaar R.J., Pishchalnikova I.V., Williams J.C. Jr, et al. Air pockets trapped during routine coupling in dry head lithotripsy can significantly decrease the delivery of shock wave energy. J Urol. 2006; N 176 (6): 2706 - 10. doi: 10.1016/j.juro.2006.07.149.

188. Jain A., Shah T.K. Effect of air bubbles in the coupling medium on efficacy of extracorporeal shock wave lithotripsy. Eur Urol. 2007; N 51 (6): 1680 - 6. doi: 10.1016/j.eururo.2006.10.049

189. Wendt-Nordahl G., Mut T., Krombach P., Michel M.S., Knoll T. Do new generation flexible ureterorenoscopes offer a higher treatment success than their predecessors? Urol Res. 2011; N 39 (3): с. 185 - 188. doi: 10.1007/s00240-010-0331-0.

190. Deng T., Liu B., Duan X., Cai C., Zhao Z., et al. Antibiotic prophylaxis in ureteroscopic lithotripsy: a systematic review and meta-analysis of comparative studies. BJU Int. 2018; N 122 (1): 29 - 39. doi: 10.1111/bju.14101.

191. Lo C.W., Yang S.S., Hsieh C.H., Chang S.J. Effectiveness of Prophylactic Antibiotics against Post-Ureteroscopic Lithotripsy Infections: Systematic Review and Meta-Analysis. Surg Infect (Larchmt). 2015; N 16 (4): 415 - 20. doi: 10.1089/sur.2014.013.

192. Martov A., Gravas S., Etemadian M,. Unsal A., Barusso G., et al. Postoperative infection rates in patients with a negative baseline urine culture undergoing ureteroscopic stone removal: a matched case-control analysis on antibiotic prophylaxis from the CROES URS global study. J Endourol. 2015; N 29 (2): 171 - 80. doi: 10.1089/end.2014.0470.

193. Chew B.H., Flannigan R., Kurtz M., Gershman B., Arsovska O., et al. A Single Dose of Intraoperative Antibiotics Is Sufficient to Prevent Urinary Tract Infection During Ureteroscopy. J Endourol. 2016; N 30 (1): 63 - 8. doi: 10.1089/end.2015.0511.

194. Dickstein R.J., Kreshover J.E., Babayan R.K., Wang D.S. Is a safety wire necessary during routine flexible ureteroscopy? J Endourol. 2010; N 24 (10): 1589 - 92. doi: 10.1089/end.2010.0145.

195. Eandi J.A., Hu B., Low R.K. Evaluation of the impact and need for use of a safety guidewire during ureteroscopy. J Endourol. 2008; N 22 (8): 1653 - 8. doi: 10.1089/end.2008.0071.

196. 00000021.wmz, Rennesund K., 00000022.wmz, Wentzel-Larsen T., Ulvik N.M. Ureteroscopy with and without safety guide wire: should the safety wire still be mandatory? J Endourol. 2013; N 27 (10): с. 1197 - 202. doi: 10.1089/end.2013.0248.

197. Molina W.R. Jr, Pessoa R.R., Silva R.D., Gustafson D., Nogueira L., et al. Is a safety guidewire needed for retrograde ureteroscopy? Rev Assoc Med Bras (1992). 2017; N 63 (8): 717 - 721. doi: 10.1590/1806-9282.63.08.717.

198. 00000023.wmz, Wentzel-Larsen T., Ulvik N.M. A safety guidewire influences the pushing and pulling forces needed to move the ureteroscope in the ureter: a clinical randomized, crossover study. J Endourol. 2013; N 27 (7): 850 - 5. doi: 10.1089/end.2013.0027.

199. Tokas T., Herrmann T.R.W., Skolarikos A., Nagele U., Training and Research in Urological Surgery and Technology (T.R.U.S.T.) Group. Pressure matters: intrarenal pressures during normal and pathological conditions, and impact of increased values to renal physiology. World J Urol. 2019; N 37 (1): 125 - 131. doi: 10.1007/s00345-018-2378-4.

200. Omar M., Noble M., Sivalingam S., El Mahdy A., Gamal A. et al. Systemic Inflammatory Response Syndrome after Percutaneous Nephrolithotomy: A Randomized Single-Blind Clinical Trial Evaluating the Impact of Irrigation Pressure. J Urol. 2016; N 196 (1): 109 - 14. doi: 10.1016/j.juro.2016.01.104.

201. Ahmed M., Pedro R.N., Kieley S., Akornor J.W., Durfee W.K., et al. Systematic evaluation of ureteral occlusion devices: insertion, deployment, stone migration, and extraction. Urology. 2009; N 73 (5): 976 - 80. doi: 10.1016/j.urology.2008.12.048.

202. Leijte J.A., Oddens J.R., Lock T.M. Holmium laser lithotripsy for ureteral calculi: predictive factors for complications and success. J Endourol. 2008; N 22 (2): 257 - 60. doi: 10.1089/end.2007.0299.

203. Pierre S., Preminger G.M. Holmium laser for stone management. World J Urol. 2007; N 25 (3): 235 - 9.

204. Garg S., Mandal A.K., Singh S.K., Naveen A., Ravimohan M., et al. Ureteroscopic laser lithotripsy versus ballistic lithotripsy for treatment of ureteric stones: a prospective comparative study. Urol Int. 2009; N 82 (3): 341 - 5. doi: 10.1159/000209369.

205. Binbay M., Tepeler A., Singh A., Akman T., Tekinaslan E., et al. Evaluation of pneumatic versus holmium: YAG laser lithotripsy for impacted ureteral stones. Int Urol Nephrol. 2011; N 43 (4): 989 - 95. doi: 10.1007/s11255-011-9951-8

206. Martov A.G., Ergakov D.V., Guseinov M.A., Andronov A.S., Dutov S.V., et al. Initial experience in clinical application of thulium laser contact lithotripsy for transurethral treatment of urolithiasis. Urologiia. 2018; 1: 112 - 120.

207. Fried N.M., Irby P.B. Advances in laser technology and fibre-optic delivery systems in lithotripsy. Nat Rev Urol. 2018; N 15 (9): 563 - 573. doi: 10.1038/s41585-018-0035-8.

208. Hardy L.A., Kennedy J.D., Wilson C.R., Irby P.B., Fried N.M. Analysis of thulium fiber laser induced bubble dynamics for ablation of kidney stones. J Biophotonics. 2017; N 10 (10): 1240 - 1249. doi: 10.1002/jbio.201600010.

209. Hardy L.A., Irby P.B., Fried N.M. Scanning electron microscopy of real and artificial kidney stones before and after Thulium fiber laser ablation in air and water. Proc. SPIE 10468, Therapeutics and Diagnostics in Urology. 2018; 104680G. doi: 10.1117/12.2285069.

210. Hardy L.A., Gonzalez D.A., Irby P.B., Fried N.M. Fragmentation and dusting of large kidney stones using compact, air-cooled, high peak power, 1940-nm, Thulium fiber laser. Therapeutics and Diagnostics in Urology. 2018; 104680O. doi: 10.1117/12.2285082

211. Yang Y., Tang Y., Bai Y., Wang X., Feng D., et al. Preoperative double-J stent placement can improve the stone-free rate for patients undergoing ureteroscopic lithotripsy: a systematic review and meta-analysis. Urolithiasis. 2018; N 46 (5): 493 - 499. doi: 10.1007/s00240-017-1012-z.

212. Assimos D., Crisci A., Culkin D., Xue W., Roelofs A., et al. CROES URS Global Study Group. Preoperative JJ stent placement in ureteric and renal stone treatment: results from the Clinical Research Office of Endourological Society (CROES) ureteroscopy (URS) Global Study. BJU Int. 2016; N 117 (4): 648 - 54. doi: 10.1111/bju.13250.

213. Jessen J.P., Breda A., Brehmer M., Liatsikos E.N., Millan R.F., et al. International Collaboration in Endourology: Multicenter Evaluation of Prestenting for Ureterorenoscopy. J Endourol. 2016; N 30 (3): 268 - 73. doi: 10.1089/end.2015.0109.

214. Ambani S.N., Faerber G.J., Roberts W.W., Hollingsworth J.M., Wolf J.S. Jr. Ureteral stents for impassable ureteroscopy. J Endourol. 2013; N 27 (5): 549 - 53. doi: 10.1089/end.2012.0414.

215. Song T., Liao B., Zheng S., Wei Q. Meta-analysis of postoperatively stenting or not in patients underwent ureteroscopic lithotripsy. Urol Res. 2012; N 40 (1): 67 - 77. doi: 10.1007/s00240-011-0385-7.

216. Pengfei S., Yutao L., Jie Y., Wuran W., Yi D., et al. The results of ureteral stenting after ureteroscopic lithotripsy for ureteral calculi: a systematic review and meta-analysis. J Urol. 2011; N 186 (5): 1904 - 9. doi: 10.1016/j.juro.2011.06.066.

217. Haleblian G., Kijvikai K., de la Rosette J., Preminger G. Ureteral stenting and urinary stone management: a systematic review. J Urol. 2008; N 179 (2): 424 - 30.

218. Nabi G., Cook J., N"Dow J., McClinton S. Outcomes of stenting after uncomplicated ureteroscopy: systematic review and meta-analysis. BMJ. 2007; N 334 (7593): 572. doi: 10.1136/bmj.39119.595081.55

219. Muslumanoglu A.Y., Fuglsig S., Frattini A., Labate G., Nadler R.B., et al. Risks and Benefits of Postoperative Double-J Stent Placement After Ureteroscopy: Results from the Clinical Research Office of Endourological Society Ureteroscopy Global Study. J Endourol. 2017; N 31 (5): 446 - 451. doi: 10.1089/end.2016.0827.

220. Brandt B., Ostri P., Lange P., Kvist K.J. Painful caliceal calculi. The treatment of small nonobstructing caliceal calculi in patients with symptoms. Scand J Urol Nephrol. 1993; N 27 (1): 75 - 6.

221. Zheng C., Xiong B., Wang H., Luo J., Zhang C., et al. Retrograde intrarenal surgery versus percutaneous nephrolithotomy for treatment of renal stones > 2 cm: a meta-analysis. Urol Int. 2014; N 93 (4): с. 417 - 24. doi: 10.1159/000363509.

222. Karakoyunlu N., Goktug G., 00000024.wmz, Zengin K., Nalbant I., et al. A comparison of standard PCNL and staged retrograde FURS in pelvis stones over 2 cm in diameter: a prospective randomized study. Urolithiasis. 2015; N 43 (3): 283 - 7. doi: 10.1007/s00240-015-0768-2.

223. Donaldson J.F., Lardas M., Scrimgeour D., Stewart F., MacLennan S., et al. Systematic review and meta-analysis of the clinical effectiveness of shock wave lithotripsy, retrograde intrarenal surgery, and percutaneous nephrolithotomy for lower-pole renal stones. Eur Urol. 2015; N 67 (4): 612 - 6. doi: 10.1016/j.eururo.2014.09.054.

224. Pearle M.S., Lingeman J.E., Leveillee R., Kuo R., Preminger G.M., et al. Prospective, randomized trial comparing shock wave lithotripsy and ureteroscopy for lower pole caliceal calculi 1 cm or less. J Urol. 2005; N 173 (6): 2005 - 9. doi: 10.1097/01.ju.0000158458.51706.56

225. Argyropoulos A.N., Tolley D.A. Evaluation of outcome following lithotripsy. Curr Opin Urol. 2010; N 20 (2): 154 - 8. doi: 10.1097/MOU.0b013e328333b68b.

226. De S., Autorino R., Kim F.J., Zargar H., Laydner H., et al. Percutaneous nephrolithotomy versus retrograde intrarenal surgery: a systematic review and meta-analysis. Eur Urol. 2015; N 67 (1): 125 - 137. doi: 10.1016/j.eururo.2014.07.003.

227. Srisubat A., Potisat S., Lojanapiwat B., Setthawong V., Laopaiboon M. Extracorporeal shock wave lithotripsy (ESWL) versus percutaneous nephrolithotomy (PCNL) or retrograde intrarenal surgery (RIRS) for kidney stones. Cochrane Database Syst Rev. 2009; N 7 (4): CD007044. doi: 10.1002/14651858.CD007044.pub2.

228. Danuser H., 00000025.wmz, Descoeudres B., Dobry E., Studer U.E. Extracorporeal shock wave lithotripsy of lower calyx calculi: how much is treatment outcome influenced by the anatomy of the collecting system? Eur Urol. 2007; N 52 (2): 539 - 46.

229. Preminger G.M. Management of lower pole renal calculi: shock wave lithotripsy versus percutaneous nephrolithotomy versus flexible ureteroscopy. Urol Res. 2006; N 34 (2): 108 - 11. doi: 10.1007/s00240-005-0020-6.

230. Manikandan R., Gall Z., Gunendran T., Neilson D., Adeyoju A. Do anatomic factors pose a significant risk in the formation of lower pole stones? Urology. 2007; N 69 (4): 620 - 4. doi: 10.1016/j.urology.2007.01.005.

231. Zhang W., Zhou T., Wu T., Gao X., Peng Y., et al. Retrograde Intrarenal Surgery Versus Percutaneous Nephrolithotomy Versus Extracorporeal Shockwave Lithotripsy for Treatment of Lower Pole Renal Stones: A Meta-Analysis and Systematic Review. J Endourol. 2015; N 29 (7): с. 745 - 59. doi: 10.1089/end.2014.0799.

232. De la Rosette J., Denstedt J., Geavlete P., Keeley F., Matsuda T., et al. CROES URS Study Group. The clinical research office of the endourological society ureteroscopy global study: indications, complications, and outcomes in 11,885 patients. J Endourol. 2014; N 28 (2): 131 - 9. doi: 10.1089/end.2013.0436.

233. Breda A., Ogunyemi O., Leppert J.T., Lam J.S., Schulam P.G. Flexible ureteroscopy and laser lithotripsy for single intrarenal stones 2 cm or greater - is this the new frontier? J Urol. 2008; N 179 (3): 981 - 4. doi: 10.1016/j.juro.2007.10.083.

234. 00000026.wmz, Sener T.E., Netsch C., Emiliani E., Pappalardo R., et al. A new single-use digital flexible ureteroscope. Cent European J Urol. 2016; N 69 (3): 302 - 305.

235. Usawachintachit M., Isaacson D.S., Taguchi K., Tzou D.T., Hsi R.S., et al. Prospective Case-Control Study Comparing LithoVue, a Single-Use, Flexible Disposable Ureteroscope, with Flexible, Reusable Fiber-Optic Ureteroscopes. J Endourol. 2017; N 31 (5): 468 - 475. doi: 10.1089/end.2017.0027.

236. Doizi S., Kamphuis G., Giusti G., Andreassen K.H., Knoll T., et al. First clinical evaluation of a new single-use flexible ureteroscope (LithoVue00000027.wmz): a European prospective multicentric feasibility study. World J Urol. 2017; N 35 (5): 809 - 818. doi: 10.1007/s00345-016-1936-x.

237. Гаджиев Н.К., Гаджиева А.Б., Моллаев Р.А., Горелов Д.С., Малхасян В.А., и др. Сравнительный обзор одноразовых гибких уретеронефроскопов. Экспериментальная и клиническая урология. 2018; N 2: с. 36 - 43

238. Chang C.L., Su L.H., Lu C.M., Tai F.T., Huang Y.C., Chang K.K. Outbreak of ertapenem-resistant Enterobacter cloacae urinary tract infections due to a contaminated ureteroscope. J Hosp Infect. 2013; N 85 (2): 118 - 24. doi: 10.1016/j.jhin.2013.06.010.

239. Akar E, Knudsen B. Flexible ureteroscopy versus percutaneous nephrolithotomy as primary treatment for renal stones 2 cm or greater. Dovepress. 2013; N 6: 1 - 10. doi: 10.2147/RMI.S28852

240. Hyams E.S., Munver R., Bird V.G., Uberoi J., Shah O. Flexible ureterorenoscopy and holmium laser lithotripsy for the management of renal stone burdens that measure 2 to 3 cm: a multi-institutional experience. J Endourol. 2010; N 24 (10): 1583 - 8. doi: 10.1089/end.2009.0629.

241. Hyams E.S., Shah O. Percutaneous nephrostolithotomy versus flexible ureteroscopy/holmium laser lithotripsy: cost and outcome analysis. J Urol. 2009; N 182 (3): 1012 - 7. doi: 10.1016/j.juro.2009.05.021. Epub 2009 Jul 18.

242. Takazawa R., Kitayama S., Tsujii T. Successful outcome of flexible ureteroscopy with holmium laser lithotripsy for renal stones 2 cm or greater. Int J Urol. 2012; N 19 (3): 264 - 7. doi: 10.1111/j.1442-2042.2011.02931.x.

243. Ricchiuti D.J., Smaldone M.C., Jacobs B.L., Smaldone A.M., Jackman S.V., et al. Staged retrograde endoscopic lithotripsy as alternative to PCNL in select patients with large renal calculi. J Endourol. 2007; N 21 (12): 1421 - 4. doi: 10.1089/end.2007.9871.

244. Aboumarzouk O.M., Monga M., Kata S.G., Traxer O., Somani B.K. Flexible ureteroscopy and laser lithotripsy for stones > 2 cm: a systematic review and meta-analysis. J Endourol. 2012; N 26 (10): 1257 - 63. doi: 10.1089/end.2012.0217.

245. Binbay M., Yuruk E., Akman T., Ozgor F., Seyrek M., et al. Is there a difference in outcomes between digital and fiberoptic flexible ureterorenoscopy procedures? J Endourol. 2010; N 24 (12): 1929 - 34. doi: 10.1089/end.2010.0211

246. Geraghty R., Abourmarzouk O., Rai B., Biyani C.S., Rukin N.J., et al. Evidence for Ureterorenoscopy and Laser Fragmentation (URSL) for Large Renal Stones in the Modern Era. Curr Urol Rep. 2015; N 16 (8): 54. doi: 10.1007/s11934-015-0529-3.

247. De Coninck V., Keller E.X., 00000028.wmz, Audouin M., Doizi S., Traxer O. Systematic review of ureteral access sheaths: facts and myths. BJU Int. 2018; N 122 (6): 959 - 969. doi: 10.1111/bju.14389.

248. Breda A., Territo A., 00000029.wmz Benefits and risks of ureteral access sheaths for retrograde renal access. Curr Opin Urol. 2016; N 26 (1): 70 - 5. doi: 10.1097/MOU.0000000000000233.

249. Traxer O., Wendt-Nordahl G., Sodha H., Rassweiler J., Meretyk S., et al. Differences in renal stone treatment and outcomes for patients treated either with or without the support of a ureteral access sheath: The Clinical Research Office of the Endourological Society Ureteroscopy Global Study. World J Urol. 2015; N 33 (12): с. 2137 - 44. doi: 10.1007/s00345-015-1582-8.

250. Yuan D., Liu Y., Rao H., Cheng T., Sun Z., et al. Supine Versus Prone Position in Percutaneous Nephrolithotomy for Kidney Calculi: A Meta-Analysis. J Endourol. 2016; N 30 (7): с. 754 - 63. doi: 10.1089/end.2015.0402.

251. Falahatkar S., Mokhtari G., Teimoori M.. An Update on Supine Versus Prone Percutaneous Nephrolithotomy: A Meta-analysis. Urol J. 2016; N 13 (5): 2814 - 2822.

252. Liu L., Zheng S., Xu Y., Wei Q. Systematic review and meta-analysis of percutaneous nephrolithotomy for patients in the supine versus prone position. J Endourol. 2010; N 24 (12): 1941 - 6. doi: 10.1089/end.2010.0292.

253. Wang K., Zhang P., Xu X., Fan M. Ultrasonographic versus Fluoroscopic Access for Percutaneous Nephrolithotomy: A Meta-Analysis. Urol Int. 2015; N 95 (1): с. 15 - 25. doi: 10.1159/000369216.

254. Liu Q., Zhou L., Cai X., Jin T., Wang K. Fluoroscopy versus ultrasound for image guidance during percutaneous nephrolithotomy: a systematic review and meta-analysis. Urolithiasis. 2017; N 45 (5): 481 - 487. doi: 10.1007/s00240-016-0934-1.

255. Ganesamoni R., Sabnis R.B., Mishra S., Parekh N., Ganpule A., et al. Prospective randomized controlled trial comparing laser lithotripsy with pneumatic lithotripsy in miniperc for renal calculi. J Endourol. 2013; N 27 (12): 1444 - 9. doi: 10.1089/end.2013.0177.

256. Istanbulluoglu M.O., Ozturk B., Gonen M., Cicek T., Ozkardes H. Effectiveness of totally tubeless percutaneous nephrolithotomy in selected patients: a prospective randomized study. Int Urol Nephrol. 2009; N 41 (3): 541 - 5. doi: 10.1007/s11255-008-9517-6.

257. Garofalo M., Pultrone C.V., Schiavina R., Brunocilla E., Sanguedolce F., et al. Tubeless procedure reduces hospitalization and pain after percutaneous nephrolithotomy: results of a multivariable analysis. Urolithiasis. 2013; N 41 (4): 347 - 53. doi: 10.1007/s00240-013-0565-8.

258. Gonen M., Cicek T., Ozkardes H. Tubeless and stentless percutaneous nephrolithotomy in patients requiring supracostal access. Urol Int. 2009; N 82 (4): 440 - 3. doi: 10.1159/000218534.

259. Gravas S., Montanari E., Geavlete P., Onal B., Skolarikos A., et al. Postoperative infection rates in low risk patients undergoing percutaneous nephrolithotomy with and without antibiotic prophylaxis: a matched case control study. J Urol. 2012; N 188 (3): 843 - 7. doi: 10.1016/j.juro.2012.05.007.

260. Малхасян В.А., Семенякин И.В., Иванов В.Ю., Сухих С.О., Гаджиев Н.К. Обзор осложнений перкутанной нефролитотомии и методов их лечения. Урология. 2018; N 4: с. 147 - 153.

261. Акопян Г.Н., Аляев Ю.Г., Рапопорт Л.М., Газимиев М.А., Акопян Г.С. Осложнения перкутанной нефролитотомии: данные литературы и собственные исследования. Вопросы урологии и андрологии. 2017; 5(3): 28 - 34. DOI: 10.20953/2307-6631-2017-3-28-34

262. Vignali C., Lonzi S., Bargellini I., Cioni R., Petruzzi P., et al. Vascular injuries after percutaneous renal procedures: treatment by transcatheter embolization. Eur Radiol. 2004; N 14 (4): 723 - 9. doi: 10.1007/s00330-003-2009-2

263. El Tayeb M.M., Knoedler J.J., Krambeck A.E., Paonessa J.E., Mellon M.J., et al. Vascular complications after percutaneous nephrolithotomy: 10 years of experience. Urology. 2015; N 85 (4): 777 - 81. doi: 10.1016/j.urology.2014.12.044.

264. Rastinehad A.R., Andonian S., Smith A.D., Siegel D.N. Management of hemorrhagic complications associated with percutaneous nephrolithotomy. J Endourol. 2009; N 23 (10): 1763 - 7. doi: 10.1089/end.2009.1548.

265. Basiri A., Tabibi A., Nouralizadeh A., Arab D., Rezaeetalab G.H., et al. Comparison of safety and efficacy of laparoscopic pyelolithotomy versus percutaneous nephrolithotomy in patients with renal pelvic stones: a randomized clinical trial. Urol J. 2014; N 11 (6): 1932 - 7.

266. Beltrami P., Ruggera L., Guttilla A., Iannetti A., Zattoni F., et al. The endourological treatment of renal matrix stones. Urol Int. 2014; N 93 (4): 394 - 8. doi: 10.1159/000357624

267. Al-Hunayan A., Khalil M., Hassabo M. et al. Management of solitary renal pelvic stone: laparoscopic retroperitoneal pyelolithotomy versus percutaneous nephrolithotomy. J. Endourol. 2011; N 25 (6): 975 - 978. doi: 10.1089/end.2010.0467.

268. Giedelman C., Arriaga J. Carmona O., de Andrade R., Banda E., et al. Laparoscopic anatrophic nephrolithotomy: developments of the technique in the era of minimally invasive surgery. J Endourol. 2012; N 26 (5): 444 - 50. doi: 10.1089/end.2011.0193.

269. Wang X., Li S., Liu T., Guo Y., Yang Z. Laparoscopic pyelolithotomy compared to percutaneous nephrolithotomy as surgical management for large renal pelvic calculi: a meta-analysis. J Urol. 2013; N 190 (3): 888 - 893. doi: 10.1016/j.juro.2013.02.092.

270. Singh V., Sinha R.J., Gupta D.K., Pandey M. Prospective randomized comparison of retroperitoneoscopic pyelolithotomy versus percutaneous nephrolithotomy for solitary large pelvic kidney stones. Urol Int. 2014; N 92 (4): 392 - 5. doi: 10.1159/000353973.

271. Kefer J.C., Turna B., Stein R.J., Desai M.M. Safety and efficacy of percutaneous nephrostolithotomy in patients on anticoagulant therapy. J Urol. 2009; N 181 (1): 144 - 8. doi: 10.1016/j.juro.2008.09.008.

272. Baron T.H., Kamath P.S., McBane R.D. Management of antithrombotic therapy in patients undergoing invasive procedures. N Engl J Med. 2013; N 368 (22): 2113 - 24. doi: 10.1056/NEJMra1206531.

273. Naspro R., Rossini R., Musumeci G., Gadda F., Pozzo L.F. Antiplatelet therapy in patients with coronary stent undergoing urologic surgery: is it still no man"s land? Eur Urol. 2013; N 64 (1): 101 - 5. doi: 10.1016/j.eururo.2013.01.026.

274. Eberli D., Chassot P.G., Sulser T., Samama C.M., Mantz J., et al. Urological surgery and antiplatelet drugs after cardiac and cerebrovascular accidents. J Urol. 2010; N 183 (6): 2128 - 36. doi: 10.1016/j.juro.2010.02.2391.

275. Mullins J.K., Semins M.J., Hyams E.S., Bohlman M.E., Matlaga B.R. Half Fourier single-shot turbo spin-echo magnetic resonance urography for the evaluation of suspected renal colic in pregnancy. Urology. 2012; N 79 (6): 1252 - 5. doi: 10.1016/j.urology.2011.12.016.

276. White W.M., Zite N.B., Gash J., Waters W.B., Thompson W., et al. Low-dose computed tomography for the evaluation of flank pain in the pregnant population. J Endourol. 2007; N 21 (11): с. 1255 - 60.

277. White W.M., Johnson E.B., Zite N.B., Beddies J., Krambeck A.E., et al. Predictive value of current imaging modalities for the detection of urolithiasis during pregnancy: a multicenter, longitudinal study. J Urol. 2013; N 189 (3): с. 931 - 4. doi: 10.1016/j.juro.2012.09.076.

278. Lloyd G.L., Lim A., Hamoui N., Nakada S.Y., Kielb S.J. The Use of Medical Expulsive Therapy During Pregnancy: A Worldwide Perspective Among Experts. J Endourol. 2016; N 30 (3): 354 - 8. doi: 10.1089/end.2015.0587.

279. Blanco LT, Socarras MR, Montero RF, et al. Renal colic during pregnancy: Diagnostic and therapeutic aspects. Literature review. Cent European J Urol. 2017; 70(1): 93 - 100. doi: 10.5173/ceju.2017.754.

280. Semins M.J., Trock B.J., Matlaga B.R. The safety of ureteroscopy during pregnancy: a systematic review and meta-analysis. J Urol. 2009; N 181 (1): 139 - 43. doi: 10.1016/j.juro.2008.09.029.

281. Parulkar B.G., Hopkins T.B., Wollin M.R., Howard P.J. Jr, Lal A. Renal colic during pregnancy: a case for conservative treatment. J Urol. 1998; N 159 (2): 365 - 8.

282. Asgari M.A., Safarinejad M.R., Hosseini S.Y., Dadkhah, F. Extracorporeal shock wave lithotripsy of renal calculi during early pregnancy. BJU Int. 1999; 84: 615 - 617.

283. 00000030.wmz, 00000031.wmz, Varga A., 00000032.wmz, Salah M.A. Percutaneous nephrolithotomy in early pregnancy. Int Urol Nephrol. 2005; N 37(1): 1 - 3.

284. Shah A., Chandak P., Tiptaft R., Glass J., Dasgupta P. Percutaneous nephrolithotomy in early pregnancy. Int J Clin Pract. 2004; N 58 (8): 809 - 10.

285. Fregonesi A., Dias F.G., Saade R.D., Dechaalani V., Reis L.O. Challenges on percutaneous nephrolithotomy in pregnancy: Supine position approach through ultrasound guidance. Urol Ann. 2013; N 5 (3): 197 - 9. doi: 10.4103/0974-7796.115750.

286. Kamphuis G.M., Baard J., Westendarp M., de la Rosette J.J. Lessons learned from the CROES percutaneous nephrolithotomy global study. World J Urol. 2015; N 33 (2): 223 - 33. doi: 10.1007/s00345-014-1367-5.

287. Committee on Obstetric Practice and the American Society of Anesthesiologists. Committee Opinion No. 696: Nonobstetric Surgery During Pregnancy. Obstet Gynecol. 2017; N 129 (4): 777 - 778. doi: 10.1097/AOG.0000000000002014.

288. Ishii H., Aboumarzouk O.M., Somani B.K. Current status of ureteroscopy for stone disease in pregnancy. Urolithiasis. 2014; N 42 (1): 1 - 7. doi: 10.1007/s00240-013-0635-y.

289. Watterson J.D., Girvan A.R., Beiko D.T., Nott L., Wollin T.A., et al. Ureteroscopy and holmium: YAG laser lithotripsy: an emerging definitive management strategy for symptomatic ureteral calculi in pregnancy. Urology. 2002; N 60 (3): 383 - 7.

290. Scotland K.B., Lange D. Prevention and management of urosepsis triggered by ureteroscopy. Res Rep Urol. 2018; 10: 43 - 49. doi: 10.2147/RRU.S128071.

291. Delvecchio F.C., Kuo R.L., Iselin C.E., Webster G.D., Preminger G.M. Combined antegrade and retrograde endoscopic approach for the management of urinary diversion-associated pathology. J Endourol. 2000; N 14 (3): 251 - 6.

292. Cohen T.D., Streem S.B., Lammert G. Long-term incidence and risks for recurrent stones following contemporary management of upper tract calculi in patients with a urinary diversion. J Urol. 1996; N 155 (1): 62 - 5.

293. Grasso M. Ureteropyeloscopic treatment of ureteral and intrarenal calculi. Urol Clin North Am. 2000; N 27 (4): 623 - 31.

294. Golomb J., Fuchs G., Klutke C.G., Stenzl A., Raz S. Kidney stone formed around refluxed surgical staple and removed by transureteral endoscopic manipulation. Urology. 1991; N 38 (4): 338 - 40.

295. Stein J.P., Freeman J.A., Esrig D., Elmajian D.A., Tarter T.H., et al. Complications of the afferent antireflux valve mechanism in the Kock ileal reservoir. J Urol. 1996; N 155 (5): с. 1579 - 84.

296. Weinerth JL, Webster GD. Experience with management of stones formed within Kock pouch continent urinary diversions. Journal of Endourology. 1990; N 4 (2): с. 149 - 154. https://doi.org/10.1089/end.1990.4.149.

297. Beiko D.T., Razvi H. Stones in urinary diversions: update on medical and surgical issues. Curr Opin Urol. 2002; N 12 (4): 297 - 303.

298. Matlaga B.R., Shah O.D., Zagoria R.J., Dyer R.B., Streem S.B., et al. Computerized tomography guided access for percutaneous nephrostolithotomy. J Urol. 2003; N 170 (1): 45 - 7.

299. Trivedi A., Patel S., Devra A., Rizvi J, Goel R., et al. Management of calculi in a donor kidney. Transplant Proc. 2007; N 39 (3): с. 761 - 2. doi: 10.1016/j.transproceed.2007.01.059

300. Rifaioglu M.M., Berger A.D., Pengune W., Stoller M.L. Percutaneous management of stones in transplanted kidneys. Urology. 2008; N 72 (3): 508 - 12. doi: 10.1016/j.urology.2008.05.040.

301. Keoghane S.R., Cetti R.J., Rogers A.E., Walmsley B.H. Blood transfusion, embolisation and nephrectomy after percutaneous nephrolithotomy (PCNL). BJU Int. 2013; N 111 (4): 628 - 32. doi: 10.1111/j.1464-410X.2012.11394.x.

302. Richstone L., Reggio E., Ost M.C., Seideman C., Fossett L.K., et al. First Prize (tie): Hemorrhage following percutaneous renal surgery: characterization of angiographic findings. J Endourol. 2008; N 22 (6): 1129 - 35. doi: 10.1089/end.2008.0061.

303. Nouralizadeh A., Ziaee S.A., Hosseini Sharifi S.H., Basiri A., Tabibi A., et al. Delayed postpercutaneous nephrolithotomy hemorrhage: prevalence, predictive factors and management. Scand J Urol. 2014; N 48 (1): 110 - 5. doi: 10.3109/21681805.2013.806586.

304. Valecha N.K., Bagheri F., Hassani S., Sadi A., Souliman R. Delayed Haematuria after Percutaneous Nephrolithotripsy and its Management. Med Sur Urol. 2017; 6(3): с. 189. doi: 10.4172/2168-9857.1000189

305. Borghi L., Meschi T., Amato F., Briganti A., Novarini A., et al. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol. 1996; N 155 (3): 839 - 43.

306. Sarica K., Inal Y., Erturhan S., 00000033.wmz The effect of calcium channel blockers on stone regrowth and recurrence after shock wave lithotripsy. Urol Res. 2006; N 34 (3): 184 - 9. doi: 10.1007/s00240-006-0040-x.

307. Fink H.A., Wilt T.J., Eidman K.E., Garimella P.S., MacDonald R., et al M. Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline. Ann Intern Med. 2013; N 158 (7): 535 - 43. doi: 10.7326/0003-4819-158-7-201304020-00005.

308. Shuster J., Jenkins A., Logan C., Barnett T., Riehle R., et al. Soft drink consumption and urinary stone recurrence: a randomized prevention trial. J Clin Epidemiol. 1992; N 45 (8): с. 911 - 6.

309. Curhan G.C., Willett W.C., Rimm E.B., Stampfer M.J. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993; N 328 (12): 833 - 8. doi: 10.1056/NEJM199303253281203.

310. Curhan G.C., Willett W.C., Speizer F.E., Spiegelman D., Stampfer M.J. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med. 1997; N 126 (7): 497 - 504.

311. Harris S.S., Dawson-Hughes B. Effects of Hydration and Calcium Supplementation on Urine Calcium Concentration in Healthy Postmenopausal Women. J Am Coll Nutr. 2015; N 34 (4): 340 - 6. doi: 10.1080/07315724.2014.959207. Epub 2015 Apr 9.

312. Borghi L., Schianchi T., Meschi T., Guerra A., Allegri F., et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002; N 346 (2): 77 - 84.

313. Fink H.A., Akornor J.W., Garimella P.S., MacDonald R., Cutting A., et al. Diet, fluid, or supplements for secondary prevention of nephrolithiasis: a systematic review and meta-analysis of randomized trials. Eur Urol. 2009; N 56 (1): 72 - 80. doi: 10.1016/j.eururo.2009.03.031.

314. Hesse A., Tiselius B.H., Siener S.R., et al. Urinary Stones: Diagnosis, Treatment and Prevention of Recurrence. Uric acid stones. 2002, S Karger AG,: Basel.

315. Parks J.H., Goldfisher E., Asplin J.R., Coe F.L. A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis. J Urol. 2002; N 167 (4): 1607 - 12.

316. Nayan M., Elkoushy M.A., Andonian S. Variations between two 24-hour urine collections in patients presenting to a tertiary stone clinic. Can Urol Assoc J. 2012; N 6 (1): 30 - 3. doi: 10.5489/cuaj.11131.

317. Ferraz R.R., Baxmann A.C., Ferreira L.G., Nishiura J.L., Siliano P.R., et al. Preservation of urine samples for metabolic evaluation of stone-forming patients. Urol Res. 2006; N 34 (5): 329 - 37.

318. Barcelo P., Wuhl O., Servitge E., Rousaud A., Pak C.Y. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol. 1993; N 150 (6): 1761 - 4.

319. Favus M.J., Coe F.L. The effects of allopurinol treatment on stone formation on hyperuricosuric calcium oxalate stone-formers. Scand J Urol Nephrol Suppl. 1980; 53: 265 - 71.

320. Cohen T.D., Streem S.B., Hall P. Clinical effect of captopril on the formation and growth of cystine calculi. J Urol. 1995; N 154 (1): 164 - 6.

321. Laerum E., Larsen S. Thiazide prophylaxis of urolithiasis. A double-blind study in general practice. Acta Med Scand. 1984; N 215 (4): 383 - 9.

322. Pearle M.S., Roehrborn C.G., Pak C.Y. Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis. J Endourol. 1999; N 13 (9): 679 - 85. doi: 10.1089/end.1999.13.679

323. Silverberg S.J., Shane E., Jacobs T.P., Siris E., Bilezikian J.P. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med. 1999; N 341 (17): 1249 - 55.

324. Miano R., Germani S., Vespasiani G. Stones and urinary tract infections. Urol Int. 2007; N 79 (1): 32 - 6. doi: 10.1159/000104439.

325. Shekarriz B., Stoller M.L. Uric acid nephrolithiasis: current concepts and controversies. J Urol. 2002; N 168 (4): 1307 - 14.

326. Assimos H.M., Chew B D., Hautmann R., Holmes R., Williams J., et al. Evaluation of the Stone Former. 2nd International consultation on Stone Disease. Health Publications, 2008; 31 - 56.

327. Pietrow P., Auge B.K., Weizer A.Z., Delvecchio F.C., Silverstein A.D., et al. Durability of the medical management of cystinuria. J Urol. 2003; N 169 (1): 68 - 70. doi: 10.1097/01.ju.0000042767.95019.76

328. Preminger G.M., Pak C.Y. Eventual attenuation of hypocalciuric response to hydrochlorothiazide in absorptive hypercalciuria. J Urol. 1987; N 137 (6): 1104 - 9.

329. Mermuys K., De Geeter F., Bacher K., Van De Moortele K., Coenegrachts K., et al. Digital tomosynthesis in the detection of urolithiasis: Diagnostic performance and dosimetry compared with digital radiography with MDCT as the reference standard. AJR Am J Roentgenol. 2010; N 195 (1): 161 - 7. doi: 10.2214/AJR.09.3075.

330. Bansal A.D., Hui J., Goldfarb D.S. Asymptomatic nephrolithiasis detected by ultrasound. Clin J Am Soc Nephrol. 2009; N 4 (3): 680 - 4. doi: 10.2215/CJN.05181008.

331. Inci K., Sahin A., Islamoglu E., Eren M.T., Bakkaloglu M., et al. Prospective long-term followup of patients with asymptomatic lower pole caliceal stones. J Urol. 2007; N 177 (6): 2189 - 92. doi: 10.1016/j.juro.2007.01.154